Craig Greven, MD
Ophthalmology · Winston Salem, NCNPI 1154304863
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,854 of the $3,521 with a category attached, or 81.1%. 12 manufacturers reported payments, led by Alcon at 27.2% of the total. 2025 is the largest year on record at $1,227, 5.7 times the $214 reported in 2019.
Across 27 payments — averaging $130.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$958
- Genentech, Inc.$613
- Genentech USA, Inc.$606
- AbbVie$258
- Apellis Pharmaceuticals, Inc.$214
- Eyepoint US, Inc.$177
- plus $696 from 6 others
Across 38 payments — averaging $9341.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$353K
- AbbVie$2K
What the payments were for
- Travel & lodging$66619%
- Food & beverage$2,85481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 4 | $958 |
| Genentech, Inc. | 5 | $613 |
| Genentech USA, Inc. | 5 | $606 |
| AbbVie(2 entities) | 2 | $258 |
| Apellis Pharmaceuticals, Inc. | 2 | $214 |
| Eyepoint US, Inc. | 3 | $177 |
| Regeneron | 1 | $147 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| Mallinckrodt Hospital Products Inc. | 1 | $120 |
| Astellas Pharma US Inc | 1 | $116 |
| Alimera Sciences, Inc. | 1 | $114 |
| Novartis | 1 | $79 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,521 in reported general payments places this provider in the 75th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 36 | $1,434 |
| Ketorolac Tromethamine | 21 | $475 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $330 |
| Timolol Maleate | 23 | $280 |
| Latanoprost | 22 | $194 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Winston Salem
- Rajiv ShahWinston Salem$909K
- Keith WalterWinston Salem$397K
- Vishak JohnWinston Salem$156K
- Jiaxi DingWinston Salem$13K
- Charles RichardsWinston Salem$9K
- Preeya GuptaRaleigh$1.8M
- Julie WoodwardDurham$1M
- Lejla VajzovicDurham$681K
- Karl StonecipherGreensboro$653K
- Terry KimDurham$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.